Table 3.
Model | Ligand | Best FEB (HHB) | Best FEB (NNB) | Residues sum (HHB+NNB) | Best Pose (HHB) | Best Pose (NNB) | Residues sum (HHB+NNB) |
---|---|---|---|---|---|---|---|
WT | ETH | 52 | 74 | 80 | 38 | 54 | 62 |
TCL | 25 | 46 | 46 | 12 | 24 | 24 | |
PIF | 23 | 35 | 35 | 22 | 32 | 34 | |
I16T | ETH | 34 | 47 | 49 | 23 | 37 | 37 |
TCL | 19 | 34 | 34 | 9 | 24 | 24 | |
PIF | 23 | 28 | 28 | 17 | 22 | 22 | |
I21V | ETH | 31 | 52 | 56 | 21 | 37 | 37 |
TCL | 18 | 40 | 40 | 11 | 24 | 25 | |
PIF | 22 | 20 | 22 | 21 | 22 | 24 | |
1ENY | ETH | 2 | 4 | 5 | 1 | 3 | 4 |
TCL | 0 | 1 | 1 | 0 | 2 | 2 | |
PIF | 2 | 2 | 2 | 0 | 2 | 2 |
The total number of receptor residues that made HHB and NNB contacts with the ligands and the union of these residues (HHB+NNB) for the Best FEB (column 5) and for the reference or Best Pose (column 8).